Smart pill bottles and video visits boost cancer drug adherence
NCT ID NCT04054557
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using telehealth visits and smart pill bottles can help breast cancer patients take their hormone therapy as prescribed. 305 women and men with early-stage hormone receptor-positive breast cancer participated. They either had regular in-person checkups or virtual visits with their oncologist and used electronic pill bottles to track medication. The goal was to see if this approach improves adherence and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- telehealth (video visits with oncologist) and smart pill bottles
- What this could lead to
- If it works, this approach could help breast cancer patients take their hormone therapy more consistently, potentially improving treatment outcomes and quality of life.
- What could go wrong
- This is a completed phase II trial, so results are available but not yet widely implemented. The benefit may vary by patient, and telehealth may not suit everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
305 people
The number who actually took part.
- Started
-
Jul 2019
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * • Signed informed consent obtained prior to any study specific assessments and procedures * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 * Women or men diagnosed with stage 0-III hormone receptor positive (estrogen receptor positive \[ER\] and /or progesterone receptor \[PR\] positive) breast cancer \* Staging for eligibility should utilize the most recent American Joint Committee on Cancer (AJCC) breast cancer staging version * Patients (Pts) must have undergone breast surgery for their diagnosis of breast cancer * Adjuvant endocrine therapy has been prescribed by their treating physician \* Patients may receive concurrent adjuvant radiation therapy plus endocrine therapy in the post-operative setting * Have a cell phone with text messaging ability * Have access to a computer, tablet, or smart phone to complete electronic surveys * Patient must be willing to setup an online Jefferson MyChart account * Patients who have been on endocrine therapy for more than 4 years Exclusion Criteria: * Pts with stage IV metastatic breast cancer * Patients unable to participate in patient portal communication (e.g. do not have either a smart phone, laptop, access to a computer and/ or access to a device with a webcam) * Pts who are non-English speaking and English illiterate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Stage 0 breast cancer ajcc V6 and V7 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jefferson Health - Asplundh Cancer Pavilion
Willow Grove, Pennsylvania, 19090, United States
-
Jefferson Health - Northeast
Torresdale, Pennsylvania, 19114, United States
-
Jefferson Health - South Jersey
Washington Township, New Jersey, 08080, United States
-
Methodist Hospital
Philadelphia, Pennsylvania, 19148, United States
-
Thomas Jefefrson University
Philadelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could shedding pounds after breast cancer keep the disease away?
- Can a triple drug combo shrink HER2-Positive breast tumors before surgery?
- Gene test could guide breast cancer treatment to boost survival
- Could a gentler chemo work for older breast cancer patients?
- Vaccine aims to block return of aggressive breast cancer
- Genetic clues in blood and tumors could personalize breast cancer care